发明名称 Pharmaceutical formulation comprising lanthanum compounds
摘要 Disclosed is a lanthanum carbonate pharmaceutical formulation in a chewable tablet comprising lanthanum carbonate in an amount from about 10 to about 40 % lanthanum, as the element, and a pharmaceutically acceptable excipient, produced by a process which comprises the steps of: a) blending the lanthanum carbonate and the pharmaceutically acceptable excipient to form a mixture; or b) blending the lanthanum carbonate and, the pharmaceutically acceptable excipient, compressing the resulting combination into a slug material or roller compacting the resulting combination into a strand material, and milling the prepared material into a free flowing mixture; and c) compressing the mixture formed in either of steps a) or b) into a tablet wherein the process is performed without wet granulation or drying.
申请公布号 NZ545633(A) 申请公布日期 2009.07.31
申请号 NZ20040545633 申请日期 2004.08.26
申请人 SHIRE HOLDINGS AG 发明人 FERDINANDO, JOSEPHINE CHRISTINE;HASLAM, ROBERT PAUL;TRESPIDI, LAURA ANNA
分类号 A61J3/10;A61K9/00;A61K9/20;A61K33/24;A61P13/12 主分类号 A61J3/10
代理机构 代理人
主权项
地址